Autologous Stem Cell Transplant Information
An autologous stem cell transplant is a treatment option for individuals with certain forms of cancer, such as lymphoma and multiple myeloma. This type of transplant does not require finding a donor, as it uses blood stem cells from the patient’s own body. At Moffitt Cancer Center, an autologous transplant is one of many treatment options that our experts may recommend for a patient. The team that makes up our Blood and Marrow Transplant and Cellular Immunotherapy Program collaborates as a tumor board to review each case and determine which treatment options are most suitable for the patient.
If an autologous transplant is recommended, the process involves:
- Collecting stem cells from the patient – Stem cells are collected from the patient over the course of one to three days. The collected stem cells are then frozen until needed.
- Conditioning the patient – Conditioning is used to provide treatment and prepare your body for the transplant. This typically involves chemotherapy or immunotherapy over the course of several days.
- Transplanting the stem cells – The stem cells are thawed and reintroduced to the patient through an IV or central line. Following the blood or bone marrow transplant, the treatment team will closely monitor the patient’s blood cell counts and track the progress to identify any issues early and help reduce the risk of complications.
Patients receiving an autologous transplant are able to undergo the entire transplant process as an outpatient. Patients will receive the same level of care as our inpatients, but are able to leave the center daily and stay in local lodging. Your transplant doctor will discuss whether outpatient transplant is an option for you.
If you would like to learn more about undergoing an autologous stem cell transplant or receiving any other cancer treatment at Moffitt, fill out a new patient registration form or call 1-888-663-3488.